• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者尿毒症期血氨的动静脉差值

Arteriovenous difference of blood ammonia in uremic patients under hemodialysis.

作者信息

Agroyannis B, Tzanatos H, Fourtounas C, Kopelias I, Katsoudas S, Chondros K

机构信息

Department of Nephrology, Aretaieon University Hospital, Athens, Greece.

出版信息

Artif Organs. 1998 Aug;22(8):703-5. doi: 10.1046/j.1525-1594.1998.06058.x.

DOI:10.1046/j.1525-1594.1998.06058.x
PMID:9702323
Abstract

In this study the ammonia concentration was determined in arterial and venous blood samples pre- and posthemodialysis (HD) in 18 uremic patients and in 18 health subjects (controls). The mean values (+/- SD) of ammonia in the arterial blood of uremic patients pre-HD were 98.32 +/- 26.55; post-HD, 63.18 +/- 17.09; and in control group patients, 72.37 +/- 10.09 micrograms/dl. In venous blood they were pre-HD, 71.70 +/- 20.68; post-HD, 58.05 +/- 16.73; and in control patients, 74.46 +/- 12.0 micrograms/dl. According to our findings, the ammonia concentration in the arterial blood of uremic patients pre-HD exceeds the normal limits and is significantly higher (p < 0.001) than that post-HD and that of control patients. The ammonia contents of venous blood pre- and post-HD ranges were within normal values, but the post-HD range was significantly lower than the pre-HD range (p < 0.05) and the control range (p < 0.01). Comparison between ammonia levels from arterial and venous blood showed significant and positive arteriovenous differences pre-HD (p < 0.001), which disappeared post-HD and were not observed in the control patients. In conclusion, uremic patients under HD present pre-HD high levels of ammonia in arterial blood with a significantly positive arteriovenous difference. In contrast, the post-HD ammonia levels in arterial and venous blood are decreased, and the arteriovenous difference is not significant.

摘要

在本研究中,测定了18例尿毒症患者和18名健康受试者(对照组)血液透析(HD)前后动脉血和静脉血样本中的氨浓度。尿毒症患者HD前动脉血中氨的平均值(±标准差)为98.32±26.55;HD后为63.18±17.09;对照组患者为72.37±10.09微克/分升。静脉血中,HD前为71.70±20.68;HD后为58.05±16.73;对照组患者为74.46±12.0微克/分升。根据我们的研究结果,尿毒症患者HD前动脉血中的氨浓度超过正常范围,并显著高于(p<0.001)HD后及对照组患者。HD前后静脉血中的氨含量均在正常范围内,但HD后的范围显著低于HD前(p<0.05)和对照组(p<0.01)。动脉血和静脉血氨水平的比较显示,HD前存在显著的正动静脉差异(p<0.001),HD后这种差异消失,且在对照组患者中未观察到。总之,接受HD的尿毒症患者HD前动脉血中氨水平较高,动静脉差异显著为正。相比之下,HD后动脉血和静脉血中的氨水平降低,动静脉差异不显著。

相似文献

1
Arteriovenous difference of blood ammonia in uremic patients under hemodialysis.血液透析患者尿毒症期血氨的动静脉差值
Artif Organs. 1998 Aug;22(8):703-5. doi: 10.1046/j.1525-1594.1998.06058.x.
2
Osmolal gap in hemodialyzed uremic patients.血液透析尿毒症患者的渗透压间隙。
Artif Organs. 2012 Jan;36(1):16-20. doi: 10.1111/j.1525-1594.2011.01293.x. Epub 2011 Aug 16.
3
Effects of end-stage renal disease and dialysis modalities on blood ammonia level.终末期肾病及透析方式对血氨水平的影响。
Hemodial Int. 2017 Jul;21(3):343-347. doi: 10.1111/hdi.12510. Epub 2016 Nov 1.
4
Changes of arterio-venous differences in pH and pCO2 by hemodialysis.血液透析对动静脉pH值和二氧化碳分压差值的影响
Int J Artif Organs. 1993 Oct;16(10):716-9.
5
Determination of arterial blood ammonia in uremic patients before and after hemodialysis using three different ammonia methods.采用三种不同的氨测定方法对尿毒症患者血液透析前后的动脉血氨进行测定。
Artif Organs. 2002 Sep;26(9):815-6; author reply 816. doi: 10.1046/j.1525-1594.2002.00925.x.
6
Relation of interdialytic water retention with apparent bicarbonate space, HCO3-, and pH in hemodialyzed uremic patients.血液透析的尿毒症患者透析间期水潴留与表观碳酸氢盐空间、HCO3-及pH的关系
Ren Fail. 2005;27(2):235-8.
7
Decreases in plasma MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in uremic patients during hemodialysis.血液透析期间尿毒症患者血浆MMP-2/TIMP-2和MMP-9/TIMP-1比值降低。
Clin Exp Nephrol. 2016 Dec;20(6):934-942. doi: 10.1007/s10157-015-1221-0. Epub 2015 Dec 28.
8
Is erythrocyte damage prevented by gardos effect in hemodialyzed uremic patients?
Artif Organs. 2000 Sep;24(9):743-5. doi: 10.1046/j.1525-1594.2000.06571.x.
9
Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients.作为尿毒症透析患者左心室肥厚病因的动脉高血压诊断和治疗不足。
Kidney Int. 2000 Jul;58(1):260-8. doi: 10.1046/j.1523-1755.2000.00161.x.
10
Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.红细胞中磷脂不对称性的丧失导致尿毒症患者贫血。
Adv Perit Dial. 2001;17:58-60.

引用本文的文献

1
Bioaccumulation of Blood Long-Chain Fatty Acids during Hemodialysis.血液长链脂肪酸在血液透析期间的生物蓄积
Metabolites. 2022 Mar 21;12(3):269. doi: 10.3390/metabo12030269.
2
Hemodialysis and Plasma Oxylipin Biotransformation in Peripheral Tissue.外周组织中的血液透析与血浆氧化脂质生物转化
Metabolites. 2022 Jan 4;12(1):34. doi: 10.3390/metabo12010034.